tiprankstipranks
Capricor Therapeutics (CAPR)
NASDAQ:CAPR
US Market

Capricor Therapeutics (CAPR) Income Statement

Compare
917 Followers

Capricor Therapeutics Income Statement

Last quarter (Q3 2024), Capricor Therapeutics's total revenue was $2.26M, a decrease of -63.44% from the same quarter last year. In Q3, Capricor Therapeutics's net income was $-12.56M. See Capricor Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 25.18M$ 2.55M$ 244.90K$ 310.25K$ 1.01M
Gross Profit
$ 24.11M$ 1.85M$ -799.00$ -8.15M$ -4.14M
Operating Expenses
$ 48.19M$ 32.25M$ 21.18M$ 14.00M$ 8.74M
Depreciation and Amortization
$ 1.07M$ 694.87K$ 245.70K$ 143.89K$ 171.96K
EBITDA
$ -23.01M$ -29.16M$ -20.69M$ -13.55M$ -7.56M
Operating Income
$ -24.08M$ -29.70M$ -20.94M$ -13.69M$ -7.73M
Other Income/Expenses
$ 1.79M$ 677.85K$ 915.92K$ 32.94K$ 92.07K
Pretax Income
$ -22.29M$ -29.02M$ -20.02M$ -13.66M$ -7.64M
Net Income
$ -22.29M-$ -19.41M$ -13.48M$ -7.38M
Per Share Metrics
Basic EPS
$ -0.83$ -1.18$ -0.84$ -0.87$ -1.99
Diluted EPS
$ -0.83$ -1.18$ -0.84$ -0.87$ -1.99
Weighted Average Shares Outstanding
26.78M 24.55M 23.09M 15.57M 3.71M
Weighted Average Shares Outstanding (Diluted)
26.78M 24.55M 23.09M 15.57M 3.71M
Currency in USD

Capricor Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis